TAS2R31
ENSG00000256436
Target class
GPCR
Chromosome
12
- Chemical probe available
- No
- Target name
- TAS2R31
- Gene name
- Taste 2 receptor member 31
- Gene symbol
- TAS2R31
- Previous gene symbols
- TAS2R44
- Protein name
- Taste receptor type 2 member 31 (T2R31) (Taste receptor type 2 member 44) (T2R44) (Taste receptor type 2 member 53) (T2R53)
- T2R31
- T2R53
- Gene biotype
- Protein coding
- Gene family
- Taste 2 receptors
- Target class
- GPCR
- Target type
- Human gene
- Tissues expressed in
- 8
- Highest tissue expression
- 1.92
- Tissue specificity (Gini)
- 0.404
- Tissue specificity (tau)
- 0.715
- KEGG gene identifiers
- hsa:259290
- Protein interaction confidence
- 0.7642
- Protein interaction partners
- 5
- R-HSA-418594
- R-HSA-420499
- R-HSA-9717207
- End position
- 11031407
- Start position
- 11030387
- Chromosome
- 12
- Strand
- Reverse
- Membrane
- Multi-pass membrane protein.
- Tissue specificity (tau)
- 0.714721
- Expression inequality (Gini)
- 0.403704
Expression in transcripts per million
- Ovary
- 1.92
- Nerve - Tibial
- 1.79
- Testis
- 1.63
- Uterus
- 1.28
- Pituitary
- 1.24
Expression in transcripts per million
- Ovary1.92
- Nerve - Tibial1.79
- Testis1.63
- Uterus1.28
- Pituitary1.24
- Cells - EBV-transformed lymphocytes1.2
- Cervix - Endocervix1.16
- Fallopian Tube1.13
- Cervix - Ectocervix0.97
- Brain - Cerebellum0.96
- Cells - Cultured fibroblasts0.83
- Thyroid0.78
- Adipose - Subcutaneous0.74
- Lung0.72
- Artery - Tibial0.71
- Breast - Mammary Tissue0.71
- Brain - Cerebellar Hemisphere0.69
- Vagina0.69
- Prostate0.68
- Esophagus - Gastroesophageal Junction0.61
- Artery - Aorta0.6
- Bladder0.59
- Artery - Coronary0.57
- Esophagus - Muscularis0.54
- Colon - Sigmoid0.54
And 29 more, listed on the interactive page.
Biological processes
- GO:0001580
- GO:0005886
- GO:0016020
Molecular functions
- GO:0033038
Related records
Trials (117)
- A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants
- A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
- A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
- A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
- A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
- A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition
- A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition
- A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
- A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants
- A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers
- A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.
- A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.
- A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine
- A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)
- A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
- A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants
- A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants
- A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
- A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
Drugs (4)
- Acesulfame
- Cyclamic acid
- Famotidine
- Saccharin